Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1983 Sep 1;158(3):885–900. doi: 10.1084/jem.158.3.885

Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E

PMCID: PMC2187113  PMID: 6193238

Abstract

Murine tumors contain low molecular weight factors that inhibit macrophage accumulation at inflammatory foci. Certain oncogenic murine leukemia viruses contain similar inhibitory activity and the active component of the retroviruses was shown to be the envelope protein P15E. A number of murine malignant and nonmalignant cell lines, as well as primary tumors, have now been examined to determine whether production of retroviral P15E or a related protein is characteristic of neoplastic cells. Tumor lines examined included the Hep 129 hepatocarcinoma, BP8 fibrosarcoma, RL1 lymphoma, and three variants of the B16 melanoma. Tumor lines were virus negative by electron microscopy. Nonmalignant cells examined included ST0, 3T3/BALB, and 3T3/L1 fibroblasts and unstimulated, as well as mitogen-stimulated murine splenocytes. Cells were pulse-labeled with [35S]methionine, proteins immunoprecipitated with two monoclonal antibodies to P15E and analyzed by SDS-PAGE and gel fluorography. All tumor lines synthesized a approximately 19,000-dalton protein that co-migrated with retroviral P15E on SDS-PAGE. None of the nonmalignant cells synthesized this protein. Two-dimensional gel electrophoresis of the proteins precipitated from two B16 melanoma lines by monoclonal anti-P15E showed them to be physicochemically similar to P15E from Rauscher leukemia virus. A competition ELISA assay for P15E was developed and confirmed the results obtained by metabolic labeling and demonstrated P15E- related antigens in the tumor cell lines and also in the ascites fluid of mice injected with Hep 129 cells. More importantly, P15E antigens were expressed in both a spontaneous mammary adenocarcinoma and in a primary methylcholanthrene-induced fibrosarcoma. Nonmalignant tissues from animals bearing these tumors contained no detectable P15E antigen. Extracts from the primary fibrosarcomas, when injected into the thighs of mice, inhibited the intraperitoneal accumulation of inflammatory macrophages. The inhibitory activity was specifically removed by absorption with monoclonal antibody to P15E. These results suggest that synthesis of the immunosuppressive retroviral protein P15E, or a very similar protein, routinely occurs during the growth of murine neoplastic cells. This P15E-related protein is present in spontaneous murine primary tumors as well as in all murine tumor cell lines tested. The expression of such proteins by transformed cells in vivo could confer a selective advantage for their sustained growth since they would be more likely to escape immune surveillance.

Full Text

The Full Text of this article is available as a PDF (1.6 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. CHANNING A. A., KASUGA T., DEMOPOULOS H. B. VIRUS PARTICLES IN B-16 AND S-91 MOUSE MELANOMAS AND THEIR SIGNIFICANCE. Lab Invest. 1965 Feb;14:219–230. [PubMed] [Google Scholar]
  2. Cerottini J. C., Brunner K. T. Cell-mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol. 1974;18:67–132. doi: 10.1016/s0065-2776(08)60308-9. [DOI] [PubMed] [Google Scholar]
  3. Cianciolo G. J., Herberman R. B., Snyderman R. Depression of murine macrophage accumulation by low-molecular-weight derived from spontaneous mammary carcinomas. J Natl Cancer Inst. 1980 Oct;65(4):829–834. doi: 10.1093/jnci/65.4.829. [DOI] [PubMed] [Google Scholar]
  4. Cianciolo G. J., Matthews T. J., Bolognesi D. P., Snyderman R. Macrophage accumulation in mice is inhibited by low molecular weight products from murine leukemia viruses. J Immunol. 1980 Jun;124(6):2900–2905. [PubMed] [Google Scholar]
  5. Cianciolo G., Hunter J., Silva J., Haskill J. S., Snyderman R. Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses. J Clin Invest. 1981 Oct;68(4):831–844. doi: 10.1172/JCI110338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ehrlich P. H., Moyle W. R., Moustafa Z. A., Canfield R. E. Mixing two monoclonal antibodies yields enhanced affinity for antigen. J Immunol. 1982 Jun;128(6):2709–2713. [PubMed] [Google Scholar]
  7. Fischinger P. J., Thiel H. J., Lieberman M., Kaplan H. S., Dunlop N. M., Robey W. G. Presence of a novel recombinant murine leukemia virus-like glycoprotein on the surface of virus-negative C57BL lymphoma cells. Cancer Res. 1982 Nov;42(11):4650–4657. [PubMed] [Google Scholar]
  8. Hausman M. S., Brosman S., Snyderman R., Mickey M. R., Fahey J. Defective monocyte function in patients with genitourinary carcinoma. J Natl Cancer Inst. 1975 Nov;55(5):1047–1054. doi: 10.1093/jnci/55.5.1047. [DOI] [PubMed] [Google Scholar]
  9. Hehlmann R., Erfle V. Biochemical studies on RNA tumor virus information and its transmission in B16 murine melanoma. Int J Cancer. 1978 Nov 15;22(5):630–638. doi: 10.1002/ijc.2910220519. [DOI] [PubMed] [Google Scholar]
  10. Karshin W. L., Arcement L. J., Naso R. B., Arlinghaus R. B. Common precursor for Rauscher leukemia virus gp69/71, p15(E), and p12(E). J Virol. 1977 Sep;23(3):787–798. doi: 10.1128/jvi.23.3.787-798.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kirschmeier P., Gattoni-Celli S., Dina D., Weinstein I. B. Carcinogen- and radiation-transformed C3H 10T1/2 cells contain RNAs homologous to the long terminal repeat sequence of a murine leukemia virus. Proc Natl Acad Sci U S A. 1982 May;79(9):2773–2777. doi: 10.1073/pnas.79.9.2773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  13. Levy M. H., Wheelock E. F. The role of macrophages in defense against neoplastic disease. Adv Cancer Res. 1974;20:131–163. doi: 10.1016/s0065-230x(08)60110-4. [DOI] [PubMed] [Google Scholar]
  14. Lieber M. M., Sherr C. J., Todaro G. J. S-tropic murine type-C viruses: frequency of isolation from continuous cell lines, leukemia virus preparations and normal spleens. Int J Cancer. 1974 May 15;13(5):587–598. doi: 10.1002/ijc.2910130503. [DOI] [PubMed] [Google Scholar]
  15. Lostrom M. E., Stone M. R., Tam M., Burnette W. N., Pinter A., Nowinski R. C. Monoclonal antibodies against murine leukemia viruses: identification of six antigenic determinants on the p 15(E) and gp70 envelope proteins. Virology. 1979 Oct 30;98(2):336–350. doi: 10.1016/0042-6822(79)90557-9. [DOI] [PubMed] [Google Scholar]
  16. Martin M. A., Bryan T., Rasheed S., Khan A. S. Identification and cloning of endogenous retroviral sequences present in human DNA. Proc Natl Acad Sci U S A. 1981 Aug;78(8):4892–4896. doi: 10.1073/pnas.78.8.4892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moroni C., Schumann G., Robert-Guroff M., Suter E. R., Martin D. Induction of endogenous murine C-type virus in spleen cell cultures treated with mitogens and 5-bromo-2'-deoxyuridine. Proc Natl Acad Sci U S A. 1975 Feb;72(2):535–538. doi: 10.1073/pnas.72.2.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nelson M., Nelson D. S. Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages. Immunology. 1978 Feb;34(2):277–290. [PMC free article] [PubMed] [Google Scholar]
  19. Normann S. J., Schardt M., Sorkin E. Anti-inflammatory effect of spontaneous lymphoma in SJL/J mice. J Natl Cancer Inst. 1979 Sep;63(3):825–833. doi: 10.1093/jnci/63.3.825. [DOI] [PubMed] [Google Scholar]
  20. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. I. A circulating factor that suppresses macrophage-mediated resistance to infection. J Exp Med. 1976 Mar 1;143(3):559–573. doi: 10.1084/jem.143.3.559. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. O'Donnell P. V., Nowinski R. C. Serological analysis of antigenic determinants on the env gene products of AKR dualtropic (MCF) murine leukemia viruses. Virology. 1980 Nov;107(1):81–88. doi: 10.1016/0042-6822(80)90274-3. [DOI] [PubMed] [Google Scholar]
  22. Pike M. C., Snyderman R. Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance. J Immunol. 1976 Oct;117(4):1243–1249. [PubMed] [Google Scholar]
  23. Repaske R., O'Neill R. R., Steele P. E., Martin M. A. Characterization and partial nucleotide sequence of endogenous type C retrovirus segments in human chromosomal DNA. Proc Natl Acad Sci U S A. 1983 Feb;80(3):678–682. doi: 10.1073/pnas.80.3.678. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Rubin R. H., Cosimi A. B., Goetzl E. J. Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma. Clin Immunol Immunopathol. 1976 Nov;6(3):376–388. doi: 10.1016/0090-1229(76)90091-x. [DOI] [PubMed] [Google Scholar]
  25. Shin H. S., Hayden M., Langley S., Kaliss N., Smith M. R. Antibody-mediated suppression of grafted lymphoma. III. Evaluation of the role of thymic function, non-thymus-derived lymphocytes, macrophages, platelets, and polymorphonuclear leukocytes in syngeneic and allogeneic hosts. J Immunol. 1975 Apr;114(4):1255–1263. [PubMed] [Google Scholar]
  26. Snyderman R., Cianciolo G. J. Further studies of a macrophage chemotaxis inhibitor (MCI) produced by neoplasms: murine tumors free of lactic dehydrogenase virus produce MCI. J Reticuloendothel Soc. 1979 Oct;26(4):453–458. [PubMed] [Google Scholar]
  27. Snyderman R., Meadows L., Holder W., Wells S., Jr Abnormal monocyte chemotaxis in patients with breast cancer: evidence for a tumor-mediated effect. J Natl Cancer Inst. 1978 Apr;60(4):737–740. doi: 10.1093/jnci/60.4.737. [DOI] [PubMed] [Google Scholar]
  28. Snyderman R., Pike M. C. An inhibitor of macrophage chemotaxis produced by neoplasms. Science. 1976 Apr 23;192(4237):370–372. doi: 10.1126/science.946556. [DOI] [PubMed] [Google Scholar]
  29. Snyderman R., Seigler H. F., Meadows L. Abnormalitieis of monocyte chemotaxis in patients with melanoma: effects of immunotherapy and tumor removal. J Natl Cancer Inst. 1977 Jan;58(1):37–41. doi: 10.1093/jnci/58.1.37. [DOI] [PubMed] [Google Scholar]
  30. Tam M. R., Green W. R., Nowinski R. C. Cytotoxic activities of monoclonal antibodies against the envelope proteins of murine leukemia virus. Cancer Res. 1980 Oct;40(10):3850–3853. [PubMed] [Google Scholar]
  31. Tennant R. W., Otten J. A., Myer F. E., Rascati R. J. Induction of retrovirus gene expression in mouse cells by some chemical mutagens. Cancer Res. 1982 Aug;42(8):3050–3055. [PubMed] [Google Scholar]
  32. Thiel H. J., Broughton E. M., Matthews T. J., Schäfer W., Bolognesi D. P. Interspecies reactivity of type C and D retrovirus p 15E and p 15C proteins. Virology. 1981 May;111(1):270–274. doi: 10.1016/0042-6822(81)90671-1. [DOI] [PubMed] [Google Scholar]
  33. Transplantable murine tumors release mouse-tropic and xenotropic type-C viruses. Int J Cancer. 1975 Apr 15;15(4):555–560. doi: 10.1002/ijc.2910150404. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES